Legis Daily

National Biotechnology Initiative Act of 2025

USA119th CongressS-1387| Senate 
| Updated: 3/19/2026
Todd Young

Todd Young

Republican Senator

Indiana

Cosponsors (1)
Alex Padilla (Democratic)

Health, Education, Labor, and Pensions Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
The bill authorizes the National Biotechnology Initiative, a comprehensive federal effort to bolster national security, economic productivity, and global competitiveness through advancements in biotechnology. This Initiative will involve numerous federal departments and agencies, including Agriculture, Commerce, Defense, Energy, and Health and Human Services, among others. Its primary goal is to coordinate and accelerate federal activities across the entire biotechnology ecosystem. Central to the Initiative's operation is the establishment of a National Biotechnology Coordination Office within the Executive Office of the President, led by a Director who will serve as the principal advisor for biotechnology. An Interagency Committee, comprising Assistant Secretary-level representatives from participating agencies, will work with the Office to oversee planning, management, and coordination. This structure ensures a unified approach to federal biotechnology efforts, preventing duplication and fostering collaboration. The Initiative mandates activities across several critical domains. It emphasizes sustained support for research and development , the creation and maintenance of robust biological data and databases , and the facilitation of private sector product commercialization . Furthermore, it seeks to achieve regulatory streamlining for biotechnology products, addressing overlaps and ambiguities to create clear pathways. Significant attention is also given to biosafety and biosecurity , developing strategies to mitigate potential threats associated with emerging biotechnologies. The bill aims to cultivate a skilled domestic workforce development through training and education programs, and to enhance public understanding through bioliteracy initiatives. It also prioritizes strengthening international partnerships through regulatory and commercial diplomacy to advance U.S. interests globally. To ensure transparency and progress, the Initiative requires the development of a comprehensive national strategy for biotechnology every five years, alongside annual reports detailing federal activities and spending. A dedicated federal website will provide public access to information, funding opportunities, and regulatory guidance. The Comptroller General will periodically review the Initiative's efficacy, providing recommendations for improvement.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Apr 9, 2025

Latest Companion Bill Action

HR 119-2756
Introduced in House
Apr 9, 2025
Introduced in Senate
Apr 9, 2025
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Mar 19, 2026
Committee on Health, Education, Labor, and Pensions. Hearings held.
  • April 9, 2025

    Latest Companion Bill Action

    HR 119-2756
    Introduced in House


  • April 9, 2025
    Introduced in Senate


  • April 9, 2025
    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.


  • March 19, 2026
    Committee on Health, Education, Labor, and Pensions. Hearings held.

Health

Related Bills

  • HR 119-2756: National Biotechnology Initiative Act of 2025
Administrative law and regulatory proceduresAdvanced technology and technological innovationsAdvisory bodiesBiological and life sciencesCongressional oversightData collection, sharing, protectionEmployment and training programsExecutive agency funding and structureExecutive Office of the PresidentGovernment information and archivesInternet, web applications, social mediaResearch administration and fundingResearch and developmentTechnology transfer and commercialization

National Biotechnology Initiative Act of 2025

USA119th CongressS-1387| Senate 
| Updated: 3/19/2026
The bill authorizes the National Biotechnology Initiative, a comprehensive federal effort to bolster national security, economic productivity, and global competitiveness through advancements in biotechnology. This Initiative will involve numerous federal departments and agencies, including Agriculture, Commerce, Defense, Energy, and Health and Human Services, among others. Its primary goal is to coordinate and accelerate federal activities across the entire biotechnology ecosystem. Central to the Initiative's operation is the establishment of a National Biotechnology Coordination Office within the Executive Office of the President, led by a Director who will serve as the principal advisor for biotechnology. An Interagency Committee, comprising Assistant Secretary-level representatives from participating agencies, will work with the Office to oversee planning, management, and coordination. This structure ensures a unified approach to federal biotechnology efforts, preventing duplication and fostering collaboration. The Initiative mandates activities across several critical domains. It emphasizes sustained support for research and development , the creation and maintenance of robust biological data and databases , and the facilitation of private sector product commercialization . Furthermore, it seeks to achieve regulatory streamlining for biotechnology products, addressing overlaps and ambiguities to create clear pathways. Significant attention is also given to biosafety and biosecurity , developing strategies to mitigate potential threats associated with emerging biotechnologies. The bill aims to cultivate a skilled domestic workforce development through training and education programs, and to enhance public understanding through bioliteracy initiatives. It also prioritizes strengthening international partnerships through regulatory and commercial diplomacy to advance U.S. interests globally. To ensure transparency and progress, the Initiative requires the development of a comprehensive national strategy for biotechnology every five years, alongside annual reports detailing federal activities and spending. A dedicated federal website will provide public access to information, funding opportunities, and regulatory guidance. The Comptroller General will periodically review the Initiative's efficacy, providing recommendations for improvement.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Apr 9, 2025

Latest Companion Bill Action

HR 119-2756
Introduced in House
Apr 9, 2025
Introduced in Senate
Apr 9, 2025
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Mar 19, 2026
Committee on Health, Education, Labor, and Pensions. Hearings held.
  • April 9, 2025

    Latest Companion Bill Action

    HR 119-2756
    Introduced in House


  • April 9, 2025
    Introduced in Senate


  • April 9, 2025
    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.


  • March 19, 2026
    Committee on Health, Education, Labor, and Pensions. Hearings held.
Todd Young

Todd Young

Republican Senator

Indiana

Cosponsors (1)
Alex Padilla (Democratic)

Health, Education, Labor, and Pensions Committee

Health

Related Bills

  • HR 119-2756: National Biotechnology Initiative Act of 2025
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Administrative law and regulatory proceduresAdvanced technology and technological innovationsAdvisory bodiesBiological and life sciencesCongressional oversightData collection, sharing, protectionEmployment and training programsExecutive agency funding and structureExecutive Office of the PresidentGovernment information and archivesInternet, web applications, social mediaResearch administration and fundingResearch and developmentTechnology transfer and commercialization